Serum C-reactive protein levels and falciparum malaria

Area of Science:

• Immunology
• Infectious Diseases
• Biochemistry

Background:

• C-reactive protein (CRP) is a key biomarker of inflammation.
• Malaria, caused by Plasmodium falciparum, is a significant health concern, especially in Africa.
• Understanding inflammatory markers in malaria endemic regions is crucial for public health.

Purpose of the Study:

• To develop a microplate ELISA for measuring C-reactive protein (CRP).
• To investigate the relationship between serum CRP levels and malaria parasitaemia in African populations.
• To compare CRP levels between malaria-infected and non-infected individuals, including a UK control group.

Main Methods:

• Development of a microplate enzyme-linked immunosorbent assay (ELISA) for CRP quantification.
• Measurement of serum CRP levels in various African groups, including children and adults with and without malaria.
• Comparison of CRP levels across different study groups and with a UK control population.

Main Results:

• Highest serum CRP levels were observed in African patients with high Plasmodium falciparum parasitaemia.
• African children with lower malaria parasitaemia still exhibited higher CRP levels compared to non-parasitaemic individuals.
• All studied African groups demonstrated significantly higher CRP levels than the UK control group.

Conclusions:

• The developed ELISA is effective for measuring CRP in relation to malaria.
• Elevated CRP levels are strongly associated with Plasmodium falciparum malaria in African populations.
• Higher baseline CRP levels in African populations, even in the absence of malaria, suggest chronic inflammatory conditions or genetic factors.